Radiopharmaceuticals are a crucial component of nuclear medicine, playing a significant role in diagnosing and treating various diseases. As the demand for accurate and efficient diagnostic tools continues to rise, the radiopharmaceuticals market share is expected to witness substantial growth in the coming years.

One of the key factors driving the market share of radiopharmaceuticals is the increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions. These diseases require precise diagnosis and targeted treatment, which can be achieved through radiopharmaceuticals. With advancements in technology and imaging techniques, radiopharmaceuticals have become an indispensable tool for healthcare professionals in accurately detecting and monitoring these diseases.

Moreover, the aging population worldwide is another significant factor contributing to the market share of radiopharmaceuticals. As individuals age, they become more susceptible to various health issues that necessitate early detection and effective treatment. Radiopharmaceuticals offer non-invasive imaging procedures that aid in identifying potential health problems at Furthermore, the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders further drives the demand for radiopharmaceuticals as they play a crucial role in accurate diagnosis and personalized treatment planning.

The Radiopharmaceuticals Market Size was valued at USD 5.07 billion in 2022, and is expected to reach USD 10.26 billion by 2030, and grow at a CAGR of 9.2% over the forecast period 2023-2030.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1070

KEY MARKET SEGMENTATION:

By Radioisotope Type

• Technetium-99
• Fluorine-18
• Iodine-131
• Leutetium-177
• Yttrium-90
• Gallium-68
• Gallium-67
• Rubidium-82
• Iodine-123
• Iodine-125
• Indium-111
• Others

By Source 

• Cyclotrons
• Nuclear Reactors

By Application

• Neurology
• Cardiology
• Oncology
• Gastroenterology
• Nephrology
• Neuroendocrinology
• others

By End-User

• Hospital & Clinics
• Diagnostic Center 
• Ambulatory Surgical Centers
• Cancer Research Institute
• Others

Some of the major key players are as follows: GE healthcare, Jubilant life sciences, Curium, JSC isotopes,  Novartis AG,  Bracco diagnostic,  Cardinalhealth, Norgine B.V, Siemens healthiness, Curium,  Lantheus Medical imaging, Australian Nuclear Science and Technology and Other Players

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com